Drug Index

GRANIX

Generic: TBO-FILGRASTIM

Review priority: STANDARD Marketing status: Prescription

Route: INJECTION
Class: General Medications
Safety profile: routine
Latest regulatory update: 21 Nov 2023, 12:00 am (UTC)

Structured Monograph

Approval overview GRANIX is listed in Drugs@FDA under application 125294 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TBO-FILGRASTIM Form and strength INJECTABLE; INJECTION - 480MCG/0.8ML Sponsor SICOR BIOTECH Submission history Latest submission status date: 2023-11-21 00:00:00. Submission type: SUPPL.